BioSpace News Archive

Deals

3 Small Biotechs Big Drugmakers are Making Googly Eyes At

A look at three small biotechs that big drugmakers are drooling over.

January 29, 2018
·
1 min read
Week in Review: Luye May Stage $500M Singapore IPO of Healthcare Assets

ARMO BioSciences completed a $128M IPO in the US after raising capital from China VCs;

January 29, 2018
·
1 min read
Business

VBI Vaccines Announces Changes to its Board of Directors

The Pontifax Group, with the nomination of Tomer Kariv, Chairman and Chief Executive Officer of The Pontifax Group, to replace Ran Nussbaum, managing partner and co-founder of The Pontifax Group.

January 29, 2018
·
5 min read
Genetown

Filing Reveals Kendall Square’s InVivo Therapeutics is Burning Through Cash Fast

With a trial on hold for more than six months, InVivo has been burning through cash and may not have enough financing to continue operations for much longer.

January 29, 2018
·
2 min read
·
Alex Keown
Business

AbbVie to Award Shareholders, Increase Employees’ Pay on Rosy 2018 Forecast

AbbVie provided an unexpectedly strong 2018 guidance revision, largely built on the new corporate tax rate.

January 29, 2018
·
2 min read
·
Mark Terry
Biotech Bay

6 Promising Biopharmas With Major Catalysts in 2018

A look at six biopharma companies that may have major stock catalysts this year.

January 29, 2018
·
4 min read
·
Mark Terry
BioMidwest

5 Drugmakers That are Soaring Insanely High Right Now

This is a market like the world has never seen.

January 29, 2018
·
1 min read
Deals

No Deal for Novo as Sanofi Swoops in With $4.85B Win for Ablynx

Only a week after Sanofi ponied up $11.6B to buy Waltham, Massachusetts-based Bioverativ, the French drugmaker is buying Ghent, Belgium-based Ablynx for $4.8B.

January 29, 2018
·
2 min read
·
Mark Terry
Drug Development

FDA Calls Roche’s Autism Drug a Breakthrough

The FDA’s Breakthrough Therapy Designation for balovaptan was primarily based on efficacy findings in the VANILLA study, a Phase II trial of balovaptan in adults with ASD.

January 29, 2018
·
2 min read
·
Alex Keown
Business

Apotex CEO Abruptly Resigns Amid Allegations of Trade Secret Leaks

Generic drug giant spokesperson says resignation is effective immediately as Desai pursues other opportunities.

January 29, 2018
·
1 min read